
EQUASHIELD - Leaders in Closed System Transfer Devices (CSTDs)
EQUASHIELD offers a wide portfolio of Closed System Transfer Devices (CSTDs) and pharmacy compounding automation solutions, protecting healthcare workers from exposure to hazardous …
- [PDF]
PROCEDURES MANUAL
transfer systems. The company's proprietary product, EQUASHIELD®, is a Closed System Transfer Device for hazardous drugs that exemplifies our credo and commitment to safety and …
Ordering - Equashield
Unlike standard syringes, Equashield® can be used safely even beyond its nominal capacity as the encapsulated plunger rod can never be detached from the syringe, preventing the potential …
EQUASHIELD® Ranked #1 Closed System Transfer Device in US …
May 22, 2025 · EQUASHIELD®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ranked as the #1 …
EQUASHIELD CSTD | ADV oncology company
EQUASHIELD® is the most advanced Closed System Transfer Device (CSTD) available. It has been recognized as the fastest and most user-friendly system in numerous peer-reviewed …
Closed System Transfer Device (CSTD) Products | EQUASHIELD
EQUASHIELD’s CSTD portfolio encompasses closed-back syringes and adaptors for a wide range of hazardous drug vials, establishing it as the most used CSTD in the USA for five …
EQUASHIELD’S SYRINGE UNIT FDA CLEARED FOR FULL-VOLUME …
Oct 3, 2023 · EQUASHIELD's unique CSTD Syringe Unit features an integrated barrier type pressure equalization system, a leak-preventing dry disconnection mechanism, and an …
vapors and aerosols. Through innovative design features, dry connectors with single motion simplicity and isolated syringe plunger, EQUASHIELD® prevents microbial ingress while it fully …
HOW IT WORKS - Equashield - Breeze Animation
EQUASHIELD® Syringe Units maintain a closed pressure equalization that prevents the escape of vapors and aerosols during compounding and administration. A unique dual-needle, air-to …
EQUASHIELD® – AAGATO MEDICAL
“We are committed to providing cost-effective technologies in cancer care”